SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,586.00    58.00 (1.28%)
Bid:
4,568.00
Ask:
4,572.00
Spread: 4.00 (0.088%)
Market Cap: £16.71b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director Declaration

25 Sep 2020 10:09

RNS Number : 1473A
Coca-Cola HBC AG
25 September 2020
 

 

 

FOR IMMEDIATE RELEASE

 

 

Coca-Cola HBC AG

Director Declaration

 

 

Zug, Switzerland - 25 September 2020 - Coca-Cola HBC AG (the "Company") has been notified that Olusola (Sola) David-Borha, independent Non-Executive Director of the Company, has been appointed a Non-Executive Director of Stanbic IBTC Holdings PLC, a company listed on the Nigerian Stock Exchange.

The appointment is effective from 24 September 2020, following receipt of all regulatory approvals.

This notification is made in accordance with the Financial Conduct Authority's Listing Rule 9.6.14R(2).

 

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary +41 (0) 41 726 01 10

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused CPG business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the societies in which we operate and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve more than 600 million consumers across a broad geographic footprint of 28 countries on 3 continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading partner brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These brands include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Royal Bliss, Costa Coffee, Valser, Romerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our more than 28,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE:CCH) and is listed on the Athens Exchange (ATHEX:EEE). For more information, please visit http://www.coca-colahellenic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNGCGDCRGDDGGU
Date   Source Headline
19th Sep 20245:04 pmRNSTransaction in Own Shares
19th Sep 20242:43 pmRNSDirector/PDMR Shareholding
18th Sep 20245:13 pmRNSTransaction in Own Shares
18th Sep 20242:40 pmRNSDirector/PDMR Shareholding
18th Sep 20247:15 amRNSTransaction in Own Shares
17th Sep 20248:01 amRNSReplacement - Composition of the Board Committees
17th Sep 20247:15 amRNSTransaction in Own Shares
16th Sep 20245:05 pmRNSComposition of the Committees of the Board
16th Sep 20244:59 pmRNSResult of Extraordinary General Meeting
11th Sep 20246:11 pmRNSTransaction in Own Shares
4th Sep 20249:37 amRNSDirector/PDMR Shareholding
4th Sep 20249:30 amRNSReplacement - Transaction in Own Shares
3rd Sep 20245:42 pmRNSTransaction in Own Shares
3rd Sep 202412:41 pmRNSDirector/PDMR Shareholding
2nd Sep 202412:20 pmRNSAthens Exchange trading date of ordinary shares
2nd Sep 202410:01 amRNSDirector/PDMR Shareholding
2nd Sep 20249:53 amRNSDirector/PDMR Shareholding
2nd Sep 20248:44 amRNSTotal Voting Rights
30th Aug 20249:21 amRNSParticipating in Barclays Conference
29th Aug 20245:01 pmRNSTransaction in Own Shares
28th Aug 20245:09 pmRNSTransaction in Own Shares
27th Aug 20245:06 pmRNSTransaction in Own Shares
23rd Aug 20245:24 pmRNSTransaction in Own Shares
23rd Aug 20248:32 amRNSNotice of EGM
22nd Aug 20245:18 pmRNSTransaction in Own Shares
21st Aug 20245:08 pmRNSTransaction in Own Shares
21st Aug 20247:10 amRNSTransaction in Own Shares
19th Aug 20245:22 pmRNSTransaction in Own Shares
19th Aug 20241:06 pmRNSDirector/PDMR Shareholding
19th Aug 20247:53 amRNSTransaction in Own Shares
16th Aug 20247:15 amRNSTransaction in Own Shares
14th Aug 20245:16 pmRNSTransaction in Own Shares
13th Aug 20245:11 pmRNSTransaction in Own Shares
12th Aug 20245:28 pmRNSTransaction in Own Shares
9th Aug 20245:22 pmRNSTransaction in Own Shares
9th Aug 202410:14 amRNSresignation of director Anna Diamantopoulou
8th Aug 20245:12 pmRNSTransaction in Own Shares
7th Aug 20247:00 amRNSStrong growth and share gains
1st Aug 202410:53 amRNSTransfer of treasuryshares and total voting rights
18th Jul 20242:33 pmRNSDirector/PDMR Shareholding
15th Jul 202412:39 pmRNSNotice of Results
1st Jul 20244:59 pmRNSTransfer of treasuryshares and total voting rights
28th Jun 20245:18 pmRNSTransaction in Own Shares
28th Jun 20241:46 pmRNSDirector/PDMR Shareholding
27th Jun 20245:08 pmRNSTransaction in Own Shares
26th Jun 20245:27 pmRNSTransaction in Own Shares
25th Jun 20245:17 pmRNSTransaction in Own Shares
24th Jun 20245:18 pmRNSTransaction in Own Shares
21st Jun 20245:11 pmRNSTransaction in Own Shares
20th Jun 20245:45 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.